Number of the records: 1
HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma
Title HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma Author Zhuang Z.P. Co-authors Yang C.Z. Ryska A. Ji Y. Hou Y.Y. Graybill S.D. Bullová Petra SAVVIR ; SAVBIOMED - Virologický ústav SAV Lubensky I.A. Kloppel G. Pacak K. Source document Endocrine-Related Cancer. Vol. 23, no. 5 (2016), p. L13-L16 Language eng - English Document kind rozpis článkov z periodík (rbx) Citations OKUBO, Yoichiro. Gangliocytic Paraganglioma: a Diagnostic Pitfall of Rare Neuroendocrine Tumor. In ENDOCRINE PATHOLOGY. ISSN 1046-3976, 2017, vol. 28, no. 2, pp. 186-186. ALMEIDA TOLEDO, Rodrigo. New HIF2 alpha inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas. In ENDOCRINE-RELATED CANCER. ISSN 1351-0088, 2017, vol. 24, no. 9, pp. C9-C19. TARADE, Daniel - ROBINSON, Claire M. - LEE, Jeffrey E. - OHH, Michael. HIF-2 alpha-pVHL complex reveals broad genotype-phenotype correlations in HIF-2 alpha-driven disease. In NATURE COMMUNICATIONS. ISSN 2041-1723, 2018, vol. 9, no., pp. OKUBO, Yoichiro - YOSHIOKA, Emi - SUZUKI, Masaki - WASHIMI, Kota - KAWACHI, Kae - KAMEDA, Yoichi - YOKOSE, Tomoyuki. Diagnosis, Pathological Findings, and Clinical Management of Gangliocytic Paraganglioma: A Systematic Review. In FRONTIERS IN ONCOLOGY. ISSN 2234-943X, 2018, vol. 8, no., pp. RENFROW, Jaclyn J. - SOIKE, Michael H. - DEBINSKI, Waldemar - RAMKISSOON, Shakti H. - MOTT, Ryan T. - FRENKEL, Mark B. - SARKARIA, Jann N. - LESSER, Glenn J. - STROWD, Roy E. Hypoxia-inducible factor 2 alpha: a novel target in gliomas. In FUTURE MEDICINAL CHEMISTRY. ISSN 1756-8919, 2018, vol. 10, no. 18, pp. 2227-2236. LOGANATHAN, S.E. - KATTARU, S. - CHANDRASEKHAR, C. - VENGAMMA, B. - SARMA, P.V.G.K. Novel mutations in EPO-R and oxygen-dependent degradation (ODD) domain of EPAS1 genes-a causative reason for Congenital Erythrocytosis. In EUROPEAN JOURNAL OF MEDICAL GENETICS. ISSN 1769-7212, JUN 2022, vol. 65, no. 6. Dostupné na: https://doi.org/10.1016/j.ejmg.2022.104493. DAVIS, L. - RECKTENWALD, M. - HUTT, E. - FULLER, S. - BRIGGS, M. - GOEL, A. - DARINGER, N. Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy. In CANCERS. MAR 2022, vol. 14, no. 5. Dostupné na: https://doi.org/10.3390/cancers14051259. ZHANG, A.L. - HUANG, Z. - TAO, W.W. - ZHAI, K. - WU, Q.L. - RICH, J.N. - ZHOU, W.C. - BAO, S.D. USP33 deubiquitinates and stabilizes HIF-2alpha to promote hypoxia response in glioma stem cells. In EMBO JOURNAL. ISSN 0261-4189, APR 4 2022, vol. 41, no. 7. Dostupné na: https://doi.org/10.15252/embj.2021109187. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2016 Registered in WOS Registered in SCOPUS Registered in CCC DOI 10.1530/ERC-16-0148 
article
File name Access Size Downloaded Type License HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma.pdf Neprístupný/archív 689.9 KB 0 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2016 2015 4.472 Q1 2.142 Q1
Number of the records: 1